RSC Bio Solutions launched FUTERRA Compressor Oils, synthetic lubricants designed to meet the performance demands of industrial and marine sectors while addressing sustainability needs.

Maritime Reporter E-News is the maritime industry's largest circulation and most authoritative ENews Service, delivered to your Email five times per week ...

Emergent BioSolutions Inc.’s stock soared 23% in premarket trade Friday, after the U.S. Food and Drug Administration approved ...

But when your company’s R&D focus is a very particular area, not all of them are going to be relevant. That’s where RSC Select comes in. RSC Select gives you on-demand access to groundbreaking ...

Emergent BioSolutions Inc. (NYSE:EBS) stock is trading higher on Wednesday after the company announced the closing of a $100 million asset-backed revolving loan facility. The Details: The new ...

(RTTNews) - Emergent BioSolutions Inc. (EBS), Monday announced the appointment of Simon Lowry as Chief Medical Officer, head of research and development, starting November 18. Previously ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Olfactive Biosolutions, the leader in harnessing food molecules for the treatment of chronic diseases, has announced the formation of its Scientific ...

There’s absolutely no doubting the playwriting pedigree of David Edgar: he’s had pieces performed at the RSC in every one of the last six decades, starting in the 1970s. He’s also the company’s ...

GAITHERSBURG, Md. - Emergent BioSolutions Inc. (NYSE:EBS), a company specializing in public health threat solutions, has announced the appointment of Dr. Simon Lowry as chief medical officer and ...

Adjusted EBITDA Guidance: $140 million to $180 million for 2024. Emergent BioSolutions Inc (NYSE:EBS) exceeded their Q2 revenue guidance, driven by strong performance in their core business areas.

Nov. 04, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS), a global company providing solutions that address public health threats and delivering life-extending products to market ...